Bristol-Myers Squibb
BMY
BMY
1,327 hedge funds and large institutions have $61.1B invested in Bristol-Myers Squibb in 2014 Q1 according to their latest regulatory filings, with 90 funds opening new positions, 461 increasing their positions, 566 reducing their positions, and 60 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
1% less capital invested
Capital invested by funds: $61.7B → $61.1B (-$592M)
12% less funds holding in top 10
Funds holding in top 10: 65 → 57 (-8)
19% less repeat investments, than reductions
Existing positions increased: 461 | Existing positions reduced: 566
Holders
1,327
Holding in Top 10
57
Calls
$856M
Puts
$741M
Top Buyers
| 1 | +$1.47B | |
| 2 | +$500M | |
| 3 | +$190M | |
| 4 |
HSBC Holdings
London,
United Kingdom
|
+$157M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$145M |
Top Sellers
| 1 | -$1.46B | |
| 2 | -$289M | |
| 3 | -$249M | |
| 4 |
MAA
Managed Account Advisors
Jersey City,
New Jersey
|
-$175M |
| 5 |
Citigroup
New York
|
-$169M |